| Vna & Hospice Of Vermont And Nh 205 Billings Farm Road Bldg 5, White River Junction, VT, 05001 | |
| (802) 463-4761 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| Name | Vna & Hospice Of Vermont And Nh |
|---|---|
| Location | 205 Billings Farm Road Bldg 5, White River Junction, Vermont |
| Hospice ID | 471506 |
| Category | Part of a Home Health Agency |
| Ownership Type | Other |
| Profit Type | OTHER |
| SSA county code | 130 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| NPI Number | 1063494698 |
| Organization Name | Visiting Nurse Association And Hospice Of Vermont And New Hampshire, I |
| Address | 88 Prospect Rd. White River Junction, Vermont, 05001 |
| Phone Number | (888)300-8853 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| NPI Number | 1104042670 |
| Organization Name | Visiting Nurse Association And Hospice Of Vermont And New Hampshire, I |
| Address | 205 Billings Farm Rd White River Junction, Vermont, 05001 |
| Phone Number | (888)300-8853 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| NPI Number | 1548486012 |
| Organization Name | Visiting Nurse Association And Hospice Of Vermont And New Hampshire, |
| Address | 205 Billings Farm Rd White River Junction, Vermont, 05001 |
| Phone Number | (888)300-8853 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| NPI Number | 1750408449 |
| Organization Name | Visiting Nurse Association And Hospice Of Vermont And New Hampshire, I |
| Address | 205 Billings Farm Rd White River Junction, Vermont, 05001 |
| Phone Number | (888)300-8853 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| NPI Number | 1790850857 |
| Organization Name | Visiting Nurse Association And Hospice Of Vermont And New Hampshire, I |
| Address | 205 Billings Farm Rd White River Junction, Vermont, 05001 |
| Phone Number | (888)300-8853 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| NPI Number | 1942327796 |
| Organization Name | Visiting Nurse Association And Hospice Of Vermont And New Hampshire, I |
| Address | 205 Billings Farm Rd White River Junction, Vermont, 05001 |
| Phone Number | (888)300-8853 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.4 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 98.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| Home Health Aides | 15.4 |
| Counselors | 1 |
| Homemakers | 11 |
| Licensed Practical or Vocational Nurses | 3.4 |
| Medical Social Workers | 3 |
| Physicians | 0.3 |
| Registered Nurses | 31.2 |
| Other Personnel | 99.3 |
| Total Employees | 164.6 |
|---|
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| Others | 3.1 |
| Total Volunteers | 3.1 |
|---|
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that it has completed its registered direct offering with several institutional investors to sell 2,550,000 units, each unit consisting of one share of Opexa common stock, a five-year Series
Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.
A study published in the current issue of Psychotherapy and Psychosomatics by a group of French investigators of the University of Paris unravels new insights as to the relationship between autoimmunity and brain function.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.
A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality.
› Verified 1 days ago
| Vna & Hospice Of Vermont And Nh Location: 205 Billings Farm Road Bldg 5, White River Junction, Vermont, 05001 Phone: (802) 463-4761 |